Chronic Rejection in the Heart
The dramatic improvements in 1-yr survival following cardiac transplantation have not been matched by similar improvements in long-term graft survival. Long-term survival of allografted hearts is limited by a progressive fibroproliferative disease, resulting in intimal thickening and occlusion of the grafted coronary vessels. This disease, variously known as accelerated transplant coronary artery disease or cardiac graft vasculopathy, is also known as chronic rejection. The histology and clinical sequelae are briefly described. The disease can be thought of as a model for nontransplant atherosclerosis, postangioplasty restenosis, and vein graft atherosclerosis. There is compelling evidence that it is driven by alloantigen-dependent mechanisms. The evolution of the disease consists of three phases, an antibody-mediated phase, a cell-mediated phase, and a phase of tissue remodeling that is dependent on cytokines and growth factors. Experimental studies show that adoptive transfer of immunglobulin can transfer features of intimal hyperplasia to transplanted arteries in immunodeficient recipients. Damage to donor endothelium is likely to be an important initiating factor in this disease because it exposes a thrombogenic subendothelial matrix. Whether T cells of antibody are most important in damaging the endothelium is currently the subject of much research. Although T cells are sometimes present in atherosclerotic lesions, an association with acute rejection has never been consistently shown.
- 人碱性成纤维生长因子(FGF-2)ELISA试剂盒 说明书
- 十年销售经验牛人浅析影响胎牛血清质量的几大因素
- 抗体产生的一般规律
- Visualizing EBV Expression Patterns by FISH
- Nonlinear Predictive Modeling of MHC Class II-Peptide Binding Using Bayesian Neural Networks
- Murine Models of Airway Inflammation
- Murine Macrophages: A Technical Approach
- Making antibodies to synthetic peptides
- Flow Cytometric Analysis of Murine T Lymphocytes: A Practical Guide
- Coning Hybridoma cDNA by RACE